Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13492)
All Articles published online
|
Publishing Process of This Article
|
Aug 14, 2016 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dondeti MF, El-Maadawy EA, Talaat RM. Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms. World J Gastroenterol 2016; 22(30): 6800-6816 [PMID: 27570418 DOI: 10.3748/wjg.v22.i30.6800] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i30/6800.htm |
| Number | Citing Articles |
| 1 |
Mazhar A. Kanak, Yoshitaro Shindo, Pavithra SaiKumar, Bashoo Naziruddin. Inflammasomes: Clinical and Therapeutic Implications. Experientia Supplementum 2018; 108: 235 doi: 10.1007/978-3-319-89390-7_10
|
| 2 |
Xu Chao, Xuesong Feng, Xiaoping Wang, Hailong Shi, Hong Li, Yuewen Wang, Lanlan Wang, Haiyu Shen, Qing Zha, Yanni Chen. MiRNA155HG polymorphisms influenced the risk of liver cancer among the Han Chinese population. BMC Medical Genetics 2020; 21(1) doi: 10.1186/s12881-020-01064-4
|
| 3 |
Kensuke Kitsugi, Kazuhito Kawata, Hidenao Noritake, Takeshi Chida, Kazuyoshi Ohta, Jun Ito, Shingo Takatori, Maho Yamashita, Tomohiko Hanaoka, Masahiro Umemura, Moe Matsumoto, Takafumi Suda. Rifaximin Improves Liver Functional Reserve by Regulating Systemic Inflammation. Journal of Clinical Medicine 2023; 12(6): 2210 doi: 10.3390/jcm12062210
|
| 4 |
Noha M. Bakr, Ashraf Awad, Emad A. Moustafa, Ahmed M. El‐Gebaly. The association between interleukin‐21 (rs2055979G/T) gene polymorphism and the risk of hepatocellular carcinoma and metastasis in patients with hepatitis C virus. Journal of Cellular Biochemistry 2019; 120(10): 18524 doi: 10.1002/jcb.29174
|
| 5 |
Yeni Ait-Ahmed, Fouad Lafdil. Immunotherapy of Hepatocellular Carcinoma. 2017; : 137 doi: 10.1007/978-3-319-64958-0_9
|
| 6 |
Linghong Guo, Honghong Ren, Lutong Pu, Xingyu Zhu, Yin Liu, Xuelei Ma. <p>The Prognostic Value of Inflammation Factors in Hepatocellular Carcinoma Patients with Hepatic Artery Interventional Treatments: A Retrospective Study</p>. Cancer Management and Research 2020; : 7173 doi: 10.2147/CMAR.S257934
|
| 7 |
Yi Quan, Jun Yang, Tao Qin, Yufang Hu. Associations between twelve common gene polymorphisms and susceptibility to hepatocellular carcinoma: evidence from a meta-analysis. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1748-8
|
| 8 |
Nadia Elwan, Nadia Elwan, Fathia Assal, Fathia Assal, Asem Elfert, Asem Elfert, Lobna AboAli, Lobna AboAli, Shaimaa Soliman, Shaimaa Soliman, Samah Soliman, Samah Soliman, Walaa Elkhalawany, Walaa Elkhalawany, Rehab Badawy, Rehab Badawy, Laila Effat, Laila Effat, Khalda Sayed, Khalda Sayed, Safinaz Shalaby, Safinaz Shalaby, Marwa Shehab, Marwa Shehab, Mohamed Abdel-Hamid, Mohamed Abdel-Hamid, Sherief Abd-Elsalam, Sherief Abd-Elsalam. Genetic Susceptibility in Family Members of Egyptian Hepatitis C Virus Infected Patients: Role of Interleukin-12 B Gene Polymorphism. Infectious Disorders - Drug Targets 2019; 19(1): 81 doi: 10.2174/1871526518666171227210541
|
| 9 |
Yin Zongyi, Li Xiaowu. Immunotherapy for hepatocellular carcinoma. Cancer Letters 2020; 470: 8 doi: 10.1016/j.canlet.2019.12.002
|
| 10 |
Mahmoud F. Dondeti, Mohamed S. Abdelkhalek, Hosam M El-Din Elezawy, Walaa F. Alsanie, Bassem M. Raafat, Amira M. Gamal-Eldeen, Roba M. Talaat. Association between interferon-gamma (IFN-γ) gene polymorphisms (+874A/T and +2109A/G), and susceptibility to hepatitis B viral infection (HBV). Journal of Applied Biomedicine 2022; 20(1): 37 doi: 10.32725/jab.2022.001
|
| 11 |
Khaled Khazim, Etti Ester Azulay, Batya Kristal, Idan Cohen. Interleukin 1 gene polymorphism and susceptibility to disease. Immunological Reviews 2018; 281(1): 40 doi: 10.1111/imr.12620
|
| 12 |
Waleed M. Elguindy, Waleed M. Serag. Cardiac echoparameters (geometry and dimensions), interleukin 6, and anthropometric measurements in Egyptian adolescents with hepatitis C and hepatocellular carcinoma. Egyptian Liver Journal 2017; 7(3 and 4): 58 doi: 10.1097/01.ELX.0000526967.41371.51
|
| 13 |
Gayatri Gouda, Manoj Kumar Gupta, Ravindra Donde, Lambodar Behera, Ramakrishna Vadde. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 109 doi: 10.1016/B978-0-323-98806-3.00007-6
|
| 14 |
Yue Chen, Haoyue Hu, Xianglei Yuan, Xue Fan, Chengda Zhang. Advances in Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.896752
|
| 15 |
Faisal Adnan, Najeeb Ullah Khan, Aqib Iqbal, Ijaz Ali, Arnolfo Petruzziello, Rocco Sabatino, Annunziata Guzzo, Giovanna Loquercio, Gerardo Botti, Sanaullah Khan, Muhammad Naeem, Muhammad Ismail Khan. Interleukin-6 polymorphisms in HCC patients chronically infected with HCV. Infectious Agents and Cancer 2020; 15(1) doi: 10.1186/s13027-020-00285-9
|
| 16 |
Zhi-Gang Gong, Weijie Zhao, Jianbing Zhang, Xi Wu, Jing Hu, Guo-Chang Yin, Yong-Jiang Xu. Metabolomics and eicosanoid analysis identified serum biomarkers for distinguishing hepatocellular carcinoma from hepatitis B virus-related cirrhosis. Oncotarget 2017; 8(38): 63890 doi: 10.18632/oncotarget.19173
|
| 17 |
Marwa O. El-Derany. Polymorphisms in Interleukin 13 Signaling and Interacting Genes Predict Advanced Fibrosis and Hepatocellular Carcinoma Development in Non-Alcoholic Steatohepatitis. Biology 2020; 9(4): 75 doi: 10.3390/biology9040075
|
| 18 |
Bothina Madkour, Alaa Gad, Mona S. Hamdy, Nariman Zahran, Mohamed Aboul-Ezz. Interleukin-6-572 promoter gene polymorphism and its association with chronic hepatitis C-induced hepatocellular carcinoma: an Egyptian study. Comparative Clinical Pathology 2018; 27(1): 161 doi: 10.1007/s00580-017-2571-7
|
| 19 |
Hanan E Al-Rashidi, Sherif Refaat, Enas Ahmed, Dalia T Hussein, Fatma M Eltantawy, Sahar Hamed. Involvement of INF-γ functional single nucleotide polymorphism +874 T/A (rs2430561) in breast cancer risk. Saudi Journal of Biological Sciences 2021; 28(11): 6289 doi: 10.1016/j.sjbs.2021.06.083
|
| 20 |
Malik Siddique Mahmood, Maryam Afzal, Hina Batool, Amara Saif, Tahreem Aqdas, Naeem Mahmood Ashraf, Mahjabeen Saleem. Screening of Pathogenic Missense Single Nucleotide Variants From LHPP Gene Associated With the Hepatocellular Carcinoma: An In silico Approach. Bioinformatics and Biology Insights 2022; 16: 117793222211155 doi: 10.1177/11779322221115547
|
| 21 |
Janett Fischer, Shuang Long, Eleni Koukoulioti, Tobias Müller, Balazs Fueloep, Renate Heyne, Mohammed Eslam, Jacob George, Fabian Finkelmeier, Oliver Waidmann, Thomas Berg, Florian van Bömmel. Association of Common Polymorphisms in the Interleukin-1 Beta Gene with Hepatocellular Carcinoma in Caucasian Patients with Chronic Hepatitis B. Pathogens 2022; 12(1): 54 doi: 10.3390/pathogens12010054
|
| 22 |
Taqveema Ali, Roli Saxena, Isha Rani, Renuka Sharma, Deepti More, Rajendra Ola, Stuti Agarwal, Yogesh Kumar Chawla, Jyotdeep Kaur. Association of interleukin-18 genotypes (−607C > A) and (−137 G > C) with the hepatitis B virus disease progression to hepatocellular carcinoma. Molecular and Cellular Biochemistry 2021; 476(11): 3923 doi: 10.1007/s11010-021-04206-1
|
| 23 |
Jiaojiao Gong, Shasha Shen, Yixuan Yang, Si Qin, Lifan Huang, Hongmin Zhang, Ling Chen, Yaqin Chen, Shiying Li, Sha She, Min Yang, Hong Ren, Huaidong Hu. Inhibition of FASN suppresses migration, invasion and growth in hepatoma carcinoma cells by deregulating the HIF-1α/IGFBP1 pathway. International Journal of Oncology 2017; 50(3): 883 doi: 10.3892/ijo.2017.3867
|
| 24 |
Prajjalendra Barooah, Snigdha Saikia, Manas Jyoti Kalita, Rituraj Bharadwaj, Preeti Sarmah, Mallika Bhattacharyya, Bhabadev Goswami, Subhash Medhi. IL-10 Polymorphisms and Haplotypes Predict Susceptibility to Hepatocellular Carcinoma Occurrence in Patients with Hepatitis C Virus Infection from Northeast India. Viral Immunology 2020; 33(6): 457 doi: 10.1089/vim.2019.0170
|
| 25 |
Zhiwei Yu, Shizong Li, Kaiqiong Wang, Dongwei Gong, Xin Qiao, Changxiong Wu. Effects of genetic polymorphisms of LINC-PINT gene on liver cancer susceptibility in the Chinese Han population. Future Oncology 2023; 19(17): 1187 doi: 10.2217/fon-2022-0669
|
| 26 |
Jun Li, Baojun Duan, Ying Guo, Rui Zhou, Jin Sun, Beibei Bie, Shuanying Yang, Chen Huang, Jun Yang, Zongfang Li. Baicalein sensitizes hepatocellular carcinoma cells to 5-FU and Epirubicin by activating apoptosis and ameliorating P-glycoprotein activity. Biomedicine & Pharmacotherapy 2018; 98: 806 doi: 10.1016/j.biopha.2018.01.002
|
| 27 |
Su Yeon An, Anca D. Petrescu, Sharon DeMorrow. Targeting Certain Interleukins as Novel Treatment Options for Liver Fibrosis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.645703
|
| 28 |
Shashi Ranjan Mani Yadav, Bela Goyal, Garima Mamgain, Ashish Kothari, Sandeep Kumar, Sarama Saha, Manisha Naithani, Anissa Atif Mirza, Raj Kumar, Rajnish Arora. Genetic Variations in IL-1β, TNF-α, and TGF-β Associated with the Severity of Chronic Cervical Spondylitis in Patients. Cells 2023; 12(12): 1594 doi: 10.3390/cells12121594
|